ENSG00000115760 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000115760 cancers 19759907
ENSG00000115760 colon cancer 21788403
ENSG00000115760 AML 22085301
ENSG00000115760 tumor 22788920
ENSG00000115760 cancer 22968445
ENSG00000115760 cancer 23211188
ENSG00000115760 non-small-cell lung cancers 23287853
ENSG00000115760 prostate cancer 23409057
ENSG00000115760 colon cancer 24187485
ENSG00000115760 epithelial ovarian cancer 24453032
ENSG00000115760 prostate cancer 25071009
ENSG00000115760 tumor 25196217
ENSG00000115760 tumor 25933218
ENSG00000115760 Breast Cancer 26191375
ENSG00000115760 cancer 26208877
ENSG00000115760 tumor 27446249
ENSG00000115760 Prostate Cancer 27663589
ENSG00000115760 gastric cancer 27685626
ENSG00000115760 non-small cell lung cancer 27768839
ENSG00000115760 cancers 28520795
ENSG00000115760 cancer 29123378
ENSG00000115760 Prostate Cancer 29429983
ENSG00000115760 tumor 29890994
ENSG00000115760 cancer 29929453
ENSG00000115760 cancers 30905357
ENSG00000115760 tumor 30931701
ENSG00000115760 cancer 30962722
ENSG00000115760 AML 30982490
ENSG00000115760 ovarian cancer 31091257
ENSG00000115760 Non-Small Cell Lung Cancer 31885751
ENSG00000115760 prostate cancer 31935634
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000115760 prostate adenocarcinoma sequence_alteration 7.084% (103/1454) 1 entry
ENSG00000115760 colon adenocarcinoma stop_gained 5.54% (40/722) 2 entries
ENSG00000115760 colorectal adenocarcinoma missense_variant 8.436% (96/1138) 3 entries
ENSG00000115760 diffuse large B-cell lymphoma sequence_alteration 2.303% (7/304) 1 entry
ENSG00000115760 small cell lung carcinoma missense_variant 1.572% (5/318) 2 entries
ENSG00000115760 Breast Carcinoma by Gene Expression Profile missense_variant 4.04% (4/99) 1 entry
ENSG00000115760 brain glioblastoma missense_variant 0.8639% (8/926) 1 entry
ENSG00000115760 lung adenocarcinoma stop_gained 5.756% (67/1164) 2 entries
ENSG00000115760 Breast Carcinoma by Gene Expression Profile sequence_alteration 4.04% (4/99) 1 entry
ENSG00000115760 breast carcinoma missense_variant 2.055% (29/1411) 2 entries
ENSG00000115760 central nervous system primitive neuroectodermal neoplasm sequence_alteration 2.928% (13/444) 1 entry
ENSG00000115760 clear cell renal carcinoma stop_gained 1.814% (25/1378) 1 entry
ENSG00000115760 rectal adenocarcinoma missense_variant 8.145% (18/221) 1 entry
ENSG00000115760 osteosarcoma sequence_alteration 1.724% (2/116) 1 entry
ENSG00000115760 colorectal adenocarcinoma stop_gained 8.436% (96/1138) 2 entries
ENSG00000115760 Ampulla of Vater Carcinoma missense_variant 3.529% (3/85) 1 entry
ENSG00000115760 female breast carcinoma missense_variant 4.12% (11/267) 1 entry
ENSG00000115760 colon adenocarcinoma sequence_alteration 5.54% (40/722) 4 entries
ENSG00000115760 breast ductal adenocarcinoma sequence_alteration 18.49% (108/584) 2 entries
ENSG00000115760 prostate carcinoma missense_variant 7.243% (31/428) 3 entries
ENSG00000115760 breast ductal adenocarcinoma missense_variant 18.49% (108/584) 1 entry
ENSG00000115760 prostate carcinoma sequence_alteration 7.243% (31/428) 2 entries
ENSG00000115760 ovarian serous adenocarcinoma stop_gained 1.189% (8/673) 1 entry
ENSG00000115760 Pancreatic Acinar Cell Carcinoma missense_variant 15.0% (3/20) 1 entry
ENSG00000115760 papillary renal cell carcinoma missense_variant 2.535% (9/355) 1 entry
ENSG00000115760 prostate adenocarcinoma missense_variant 7.084% (103/1454) 2 entries
ENSG00000115760 chronic lymphocytic leukemia frameshift_variant 3.829% (35/914) 2 entries
ENSG00000115760 acute lymphoblastic leukemia missense_variant 0.9346% (3/321) 1 entry
ENSG00000115760 HER2 Positive Breast Carcinoma missense_variant 24.07% (26/108) 2 entries
ENSG00000115760 Gallbladder Adenocarcinoma missense_variant 2.299% (2/87) 2 entries
ENSG00000115760 head and neck squamous cell carcinoma missense_variant 1.757% (11/626) 1 entry
ENSG00000115760 rectal adenocarcinoma sequence_alteration 8.145% (18/221) 1 entry
ENSG00000115760 esophageal squamous cell carcinoma stop_gained 3.852% (26/675) 1 entry
ENSG00000115760 gastric intestinal type adenocarcinoma stop_gained 10.59% (9/85) 1 entry
ENSG00000115760 diffuse large B-cell lymphoma missense_variant 2.303% (7/304) 2 entries
ENSG00000115760 non-small cell lung carcinoma missense_variant 9.434% (5/53) 1 entry
ENSG00000115760 oral squamous cell carcinoma missense_variant 5.742% (12/209) 3 entries
ENSG00000115760 cecum adenocarcinoma missense_variant 8.0% (10/125) 2 entries
ENSG00000115760 gastric adenocarcinoma missense_variant 4.48% (25/558) 2 entries
ENSG00000115760 pancreatic ductal adenocarcinoma missense_variant 6.99% (88/1259) 1 entry
ENSG00000115760 female breast carcinoma stop_gained 4.12% (11/267) 1 entry
ENSG00000115760 colon adenocarcinoma missense_variant 5.54% (40/722) 5 entries
ENSG00000115760 HER2 Positive Breast Carcinoma stop_gained 24.07% (26/108) 1 entry
ENSG00000115760 rectal adenocarcinoma stop_gained 8.145% (18/221) 1 entry
ENSG00000115760 esophageal adenocarcinoma missense_variant 14.61% (64/438) 1 entry
ENSG00000115760 Invasive Breast Carcinoma stop_gained 12.77% (6/47) 1 entry
ENSG00000115760 skin melanoma stop_gained 5.584% (54/967) 1 entry
ENSG00000115760 neoplasm missense_variant 7.143% (2/28) 1 entry
ENSG00000115760 melanoma missense_variant 7.921% (8/101) 2 entries
ENSG00000115760 rectal adenocarcinoma frameshift_variant 8.145% (18/221) 2 entries
ENSG00000115760 central nervous system primitive neuroectodermal neoplasm missense_variant 2.928% (13/444) 2 entries
ENSG00000115760 Merkel cell skin cancer sequence_alteration 6.667% (2/30) 1 entry
ENSG00000115760 metaplastic breast carcinoma missense_variant 3.922% (2/51) 1 entry
ENSG00000115760 ovarian serous adenocarcinoma missense_variant 1.189% (8/673) 1 entry
ENSG00000115760 myelodysplastic syndrome sequence_alteration 2.703% (2/74) 1 entry
ENSG00000115760 squamous cell lung carcinoma missense_variant 5.118% (39/762) 1 entry
ENSG00000115760 clear cell renal carcinoma missense_variant 1.814% (25/1378) 3 entries
ENSG00000115760 colorectal adenocarcinoma frameshift_variant 8.436% (96/1138) 1 entry
ENSG00000115760 skin melanoma missense_variant 5.584% (54/967) 5 entries
ENSG00000115760 lung adenocarcinoma sequence_alteration 5.756% (67/1164) 3 entries
ENSG00000115760 bile duct adenocarcinoma missense_variant 1.058% (2/189) 2 entries
ENSG00000115760 esophageal squamous cell carcinoma missense_variant 3.852% (26/675) 5 entries
ENSG00000115760 Cervical Small Cell Carcinoma missense_variant 50.0% (3/6) 1 entry
ENSG00000115760 clear cell renal carcinoma sequence_alteration 1.814% (25/1378) 1 entry
ENSG00000115760 squamous cell lung carcinoma sequence_alteration 5.118% (39/762) 1 entry
ENSG00000115760 papillary renal cell carcinoma stop_gained 2.535% (9/355) 1 entry
ENSG00000115760 gastric intestinal type adenocarcinoma frameshift_variant 10.59% (9/85) 1 entry
ENSG00000115760 Invasive Breast Carcinoma missense_variant 12.77% (6/47) 1 entry
ENSG00000115760 Pleural Epithelioid Mesothelioma missense_variant 1.266% (2/158) 1 entry
ENSG00000115760 gastric intestinal type adenocarcinoma missense_variant 10.59% (9/85) 2 entries
ENSG00000115760 hepatocellular carcinoma missense_variant 3.88% (35/902) 2 entries
ENSG00000115760 brain glioblastoma sequence_alteration 0.8639% (8/926) 2 entries
ENSG00000115760 colon adenocarcinoma frameshift_variant 5.54% (40/722) 1 entry
ENSG00000115760 bladder carcinoma missense_variant 8.649% (48/555) 1 entry
ENSG00000115760 unspecified peripheral T-cell lymphoma missense_variant 33.33% (3/9) 1 entry
ENSG00000115760 prostate adenocarcinoma stop_gained 7.084% (103/1454) 1 entry
ENSG00000115760 basal cell carcinoma missense_variant 15.52% (9/58) 1 entry
ENSG00000115760 melanoma stop_gained 7.921% (8/101) 1 entry
ENSG00000115760 chronic lymphocytic leukemia missense_variant 3.829% (35/914) 4 entries
ENSG00000115760 angiosarcoma sequence_alteration 15.38% (2/13) 1 entry
ENSG00000115760 gastric intestinal type adenocarcinoma sequence_alteration 10.59% (9/85) 2 entries
ENSG00000115760 lung adenocarcinoma missense_variant 5.756% (67/1164) 6 entries
ENSG00000115760 diffuse gastric adenocarcinoma missense_variant 3.797% (3/79) 2 entries
ENSG00000115760 colorectal adenocarcinoma sequence_alteration 8.436% (96/1138) 2 entries
ENSG00000115760 Borderline Ovarian Mucinous Tumor stop_gained 12.5% (1/8) 1 entry
ENSG00000115760 diffuse gastric adenocarcinoma sequence_alteration 3.797% (3/79) 1 entry
ENSG00000115760 cecum adenocarcinoma stop_gained 8.0% (10/125) 1 entry
ENSG00000115760 small cell lung carcinoma sequence_alteration 1.572% (5/318) 1 entry
ENSG00000115760 ependymoma sequence_alteration 4.348% (2/46) 1 entry
ENSG00000115760 non-small cell lung carcinoma sequence_alteration 9.434% (5/53) 1 entry
ENSG00000115760 neoplasm of mature B-cells missense_variant 2.941% (1/34) 1 entry
ENSG00000115760 renal carcinoma sequence_alteration 14.29% (1/7) 1 entry
ENSG00000115760 Invasive Breast Carcinoma sequence_alteration 12.77% (6/47) 1 entry
ENSG00000115760 colorectal adenoma missense_variant 22.22% (2/9) 1 entry
ENSG00000115760 female breast carcinoma frameshift_variant 4.12% (11/267) 1 entry
ENSG00000115760 clear cell renal carcinoma frameshift_variant 1.814% (25/1378) 1 entry
ENSG00000115760 prostate adenocarcinoma frameshift_variant 7.084% (103/1454) 1 entry
ENSG00000115760 large cell lung carcinoma missense_variant 5.556% (1/18) 1 entry
ENSG00000115760 prostate carcinoma frameshift_variant 7.243% (31/428) 1 entry
ENSG00000115760 Non-Functioning Adrenal Cortex Adenoma missense_variant 4.545% (1/22) 1 entry
ENSG00000115760 Pleural Biphasic Mesothelioma missense_variant 1.449% (1/69) 1 entry
ENSG00000115760 head and neck squamous cell carcinoma frameshift_variant 1.757% (11/626) 1 entry
ENSG00000115760 bladder transitional cell carcinoma missense_variant 1.46% (2/137) 1 entry
ENSG00000115760 adenosquamous lung carcinoma missense_variant 9.091% (1/11) 1 entry
ENSG00000115760 rectal neoplasm sequence_alteration 20.0% (1/5) 1 entry
ENSG00000115760 testicular seminoma missense_variant 7.692% (1/13) 1 entry
ENSG00000115760 adrenal cortex carcinoma missense_variant 0.6098% (1/164) 1 entry
ENSG00000115760 Small Intestinal Enteropathy-Associated T-Cell Lymphoma missense_variant 100.0% (1/1) 1 entry
ENSG00000115760 anaplastic oligodendroglioma missense_variant 2.381% (1/42) 1 entry
ENSG00000115760 nasopharyngeal squamous cell carcinoma missense_variant 0.5988% (1/167) 1 entry
ENSG00000115760 lung adenocarcinoma frameshift_variant 5.756% (67/1164) 1 entry
ENSG00000115760 laryngeal squamous cell carcinoma missense_variant 3.846% (1/26) 1 entry
ENSG00000115760 endometrial carcinoma frameshift_variant 4.348% (1/23) 1 entry
ENSG00000115760 large cell lung carcinoma stop_gained 5.556% (1/18) 1 entry
ENSG00000115760 bladder transitional cell carcinoma frameshift_variant 1.46% (2/137) 1 entry
ENSG00000115760 Benign Adrenal Gland Pheochromocytoma missense_variant 3.03% (1/33) 1 entry
ENSG00000115760 malignant peripheral nerve sheath tumor missense_variant 50.0% (1/2) 1 entry
ENSG00000115760 adrenal gland pheochromocytoma missense_variant 0.5128% (1/195) 1 entry
ENSG00000115760 Cortisol-Producing Adrenal Cortex Adenoma missense_variant 0.8065% (1/124) 1 entry
ENSG00000115760 diffuse large B-cell lymphoma frameshift_variant 2.303% (7/304) 1 entry
ENSG00000115760 rectum adenoma missense_variant 33.33% (1/3) 1 entry
ENSG00000115760 ependymoma missense_variant 4.348% (2/46) 1 entry
ENSG00000115760 Ampulla of Vater Carcinoma stop_gained 3.529% (3/85) 1 entry
ENSG00000115760 bronchoalveolar adenocarcinoma missense_variant 4.545% (1/22) 1 entry
ENSG00000115760 mucosal melanoma missense_variant 7.143% (1/14) 1 entry
ENSG00000115760 meningioma (disease) missense_variant 2.041% (1/49) 1 entry
ENSG00000115760 basal cell carcinoma sequence_alteration 15.52% (9/58) 1 entry
ENSG00000115760 colorectal adenoma stop_gained 22.22% (2/9) 1 entry
ENSG00000115760 adrenocortical adenoma missense_variant 2.5% (1/40) 1 entry
ENSG00000115760 acute lymphoblastic leukemia sequence_alteration 0.9346% (3/321) 1 entry
ENSG00000115760 pseudomyxoma peritonei missense_variant 10.0% (1/10) 1 entry
ENSG00000115760 small cell lung carcinoma stop_gained 1.572% (5/318) 1 entry
ENSG00000115760 chronic myelomonocytic leukemia missense_variant 3.704% (1/27) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000115760 MESO 0.05 high
ENSG00000115760 UVM 0.012 high
ENSG00000115760 PAAD 0.04 high
ENSG00000115760 UCEC 0.0026 high
ENSG00000115760 ACC 0.0016 high
ENSG00000115760 HNSC 0.027 low
ENSG00000115760 READ 0.0037 low
ENSG00000115760 KIRP 0.013 high
ENSG00000115760 KICH 0.02 high
ENSG00000115760 LUAD 0.036 low
ENSG00000115760 THYM 0.046 low
ENSG00000115760 BRCA 0.029 high
ENSG00000115760 COAD 0.025 high
ENSG00000115760 PRAD 0.025 high
ENSG00000115760 LAML 0.00027 low
ENSG00000115760 GBM 0.0026 low
ENSG00000115760 CESC 0.011 high
ENSG00000115760 LIHC 0.022 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000115760 TGCT Amp 0.854436 0.124596 0.414887 0.393333